Canopy Growth (CGC) Short term Debt (2017 - 2026)
Canopy Growth (CGC) reported Short term Debt of $11.8 million for Q1 2026, up 299.0% on a YoY basis from $3.0 million in Q1 2025, and up 782.21% sequentially from $1.3 million in Q3 2025.
Canopy Growth (CGC) Short term Debt (2017 - 2026) Analysis & Trends
Canopy Growth (CGC) has 10 years of Short term Debt data on file, last reported at $11.8 million in Q1 2026.
- For the quarter ending Q1 2026, Short term Debt rose 299.0% year-over-year to $11.8 million; the trailing twelve-month figure through Mar 2026 stood at $11.8 million (up 299.0% YoY), and the FY2026 full-year result was $11.8 million, up 299.0% from the prior year.
- Short term Debt grew to $11.8 million in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $411.9 million in Q1 2023 to a low of $1.3 million in Q3 2025.
- A 5-year average of $103.0 million and a median of $52.2 million in 2023 frame the typical range for Short term Debt.
- Across the five-year window, Short term Debt jumped 5512.91% in 2023 and tumbled 99.05% in 2024, its largest moves.
- Tracing CGC's Short term Debt over 5 years: stood at $335.6 million in 2022, then sank by 80.01% to $67.1 million in 2023, then plunged by 96.62% to $2.3 million in 2024, then tumbled by 40.8% to $1.3 million in 2025, then jumped by 782.21% to $11.8 million in 2026.
- Business Quant data shows CGC's Short term Debt at $11.8 million in Q1 2026, $1.3 million in Q3 2025, and $4.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.84 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 4.55 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 2.27 Mn |
| Sep 30, 2024 | 101.10 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 77.13 Mn |
| Dec 31, 2023 | 67.09 Mn |
| Sep 30, 2023 | 37.27 Mn |
| Jun 30, 2023 | 188.27 Mn |
| Mar 31, 2023 | 411.93 Mn |
| Dec 31, 2022 | 335.56 Mn |
| Sep 30, 2022 | 246.87 Mn |
| Jun 30, 2022 | 151.43 Mn |
| Mar 31, 2022 | 7.34 Mn |
| Dec 31, 2021 | 12.46 Mn |
| Sep 30, 2021 | 7.01 Mn |
| Jun 30, 2021 | 12.78 Mn |
| Mar 31, 2021 | 7.76 Mn |